AMDR Applauds Federal Court Decision to Bar Johnson & Johnson’s Biosense Webster Unit from Further Violation of Anti-Trust Laws in a Win for Hospitals, Patients, and the Environment
Yesterday Court Issued Final Injunction After Jury Finds that Biosense Webster’s Unlawful, Anti-Competitive Practices Forced Hospitals to Purchase More Costly, Wasteful Products [Washington, D.C. — August 28, 2025] — The Association of Medical Device Reprocessors
STATEMENT – Innovative Health Seeks Permanent Injunction Against Johnson & Johnson Medtech’s Biosense Webster Following Landmark Antitrust Win
Motion filed includes evidence and testimony presented at trial demonstrating the lengths Johnson & Johnson MedTech’s Biosense Webster went to “crush” reprocessor competitors June 20, 2025 FOR IMMEDIATE RELEASE [Note to Editors: The case information
Triple Damages — $442M — Awarded to AMDR Member Innovative Health in Case Against Johnson & Johnson’s Biosense Webster Medical Technology Unit for Withholding Technical Support When Reprocessed Devices Were Used
[Washington, D.C. and Berlin, Germany / 5 June 2025] Today, Judge James V. Selna of the U.S. District Court for the Central District of California entered judgment in Innovative Health LLC v. Biosense Webster, Inc.,